NCT03195777View on ClinicalTrials.gov

Novel PET/CT and Treatment Strategies to Reduce PTS Following DVT

NAActive, not recruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

December 20, 2017

Primary Completion Date

April 3, 2025

Study Completion Date

April 2, 2026

Conditions
Deep Venous ThrombosisPost-thrombotic Syndrome
Interventions
DEVICE

PET/CT

PET/CT imaging will be performed (with fluorodeoxyglucose, \[FDG\] as a tracer). Thereafter, subjects will be monitored for development of PTS. We will then assess the ability of PET/CT top predict the subsequent development of PTS.

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
lead

Massachusetts General Hospital

OTHER

NCT03195777 - Novel PET/CT and Treatment Strategies to Reduce PTS Following DVT | Biotech Hunter | Biotech Hunter